Your browser doesn't support javascript.
loading
The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea.
Manock, Stephen R; Nsue, Vicente Urbano; Olotu, Ally; Mpina, Maximillian; Nyakarungu, Elizabeth; Raso, José; Mtoro, Ali; Ondo Mangue, Martín Eka; Ntutumu Pasialo, Beltrán Ekua; Nguema, Rufino; Riyahi, Pouria; Schindler, Tobias; Daubenberger, Claudia; Church, L W Preston; Billingsley, Peter F; Richie, Thomas L; Abdulla, Salim; Hoffman, Stephen L.
Afiliação
  • Manock SR; Sanaria Inc., Rockville, MD 20850, USA.
  • Nsue VU; Department of Family Medicine, John Peter Smith Hospital, Fort Worth, TX 76104, USA.
  • Olotu A; National Malaria Control Program, Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
  • Mpina M; Department of Interventions & Clinical Trials, Ifakara Health Institute, Box 74, Bagamoyo, Tanzania.
  • Nyakarungu E; KEMRI Wellcome Trust Research Programme, P.O. Box 230-80108 Kilifi, Kenya.
  • Raso J; Department of Interventions & Clinical Trials, Ifakara Health Institute, Box 74, Bagamoyo, Tanzania.
  • Mtoro A; Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland.
  • Ondo Mangue ME; University of Basel, Petersplatz 1, 4001 Basel, Switzerland.
  • Ntutumu Pasialo BE; Department of Interventions & Clinical Trials, Ifakara Health Institute, Box 74, Bagamoyo, Tanzania.
  • Nguema R; National Malaria Control Program, Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
  • Riyahi P; Department of Interventions & Clinical Trials, Ifakara Health Institute, Box 74, Bagamoyo, Tanzania.
  • Schindler T; National Malaria Control Program, Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
  • Daubenberger C; National Malaria Control Program, Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
  • Church LWP; National Program for Onchocerciasis and Other Filariasis Control, Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
  • Billingsley PF; Sanaria Inc., Rockville, MD 20850, USA.
  • Richie TL; Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland.
  • Abdulla S; University of Basel, Petersplatz 1, 4001 Basel, Switzerland.
  • Hoffman SL; Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland.
Trans R Soc Trop Med Hyg ; 116(8): 745-749, 2022 08 05.
Article em En | MEDLINE | ID: mdl-35394038

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas Limite: Animals / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas Limite: Animals / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022